Tersteeg et al. developed a rat model by injecting polyclonal anti-ADAMTS13 antibodies, additional infusion of recombinant vWF was required to induce the clinical syndrome of TTP. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.